Sg Americas Securities, LLC Denali Therapeutics Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 4,808 shares of DNLI stock, worth $99,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,808
Previous 13,808 65.18%
Holding current value
$99,092
Previous $321,000 56.39%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
SELL
$20.96 - $31.05 $188,640 - $279,450
-9,000 Reduced 65.18%
4,808 $140,000
Q2 2024

Jul 12, 2024
BUY
$14.96 - $23.22 $99,738 - $154,807
6,667 Added 93.36%
13,808 $321,000
Q1 2024

May 06, 2024
BUY
$15.83 - $23.35 $113,042 - $166,742
7,141 New
7,141 $147,000
Q3 2023

Oct 13, 2023
BUY
$20.63 - $30.17 $543,105 - $794,255
26,326 Added 277.88%
35,800 $739,000
Q2 2023

Jul 10, 2023
SELL
$23.37 - $32.96 $650,083 - $916,848
-27,817 Reduced 74.59%
9,474 $280,000
Q1 2023

Apr 28, 2023
BUY
$21.91 - $32.67 $717,442 - $1.07 Million
32,745 Added 720.3%
37,291 $859,000
Q4 2022

Feb 02, 2023
SELL
$26.28 - $33.92 $218,255 - $281,705
-8,305 Reduced 64.63%
4,546 $126,000
Q3 2022

Oct 31, 2022
SELL
$25.97 - $38.53 $687,296 - $1.02 Million
-26,465 Reduced 67.31%
12,851 $394,000
Q2 2022

Jul 29, 2022
BUY
$20.88 - $35.19 $633,415 - $1.07 Million
30,336 Added 337.82%
39,316 $1.16 Million
Q1 2022

Apr 29, 2022
SELL
$29.0 - $47.27 $690,838 - $1.13 Million
-23,822 Reduced 72.62%
8,980 $289,000
Q4 2021

Feb 07, 2022
BUY
$42.59 - $55.02 $81,219 - $104,923
1,907 Added 6.17%
32,802 $1.46 Million
Q3 2021

Nov 01, 2021
BUY
$48.48 - $78.23 $660,540 - $1.07 Million
13,625 Added 78.89%
30,895 $1.56 Million
Q2 2021

Aug 12, 2021
SELL
$50.3 - $78.44 $498,372 - $777,183
-9,908 Reduced 36.46%
17,270 $1.36 Million
Q1 2021

May 13, 2021
BUY
$53.8 - $81.53 $83,874 - $127,105
1,559 Added 6.09%
27,178 $1.55 Million
Q4 2020

Feb 04, 2021
SELL
$36.89 - $93.56 $2.12 Million - $5.38 Million
-57,528 Reduced 69.19%
25,619 $2.15 Million
Q3 2020

Nov 09, 2020
BUY
$23.13 - $38.84 $1.45 Million - $2.44 Million
62,766 Added 307.96%
83,147 $2.98 Million
Q2 2020

Jul 20, 2020
SELL
$16.01 - $28.82 $30,499 - $54,902
-1,905 Reduced 8.55%
20,381 $493,000
Q1 2020

Apr 30, 2020
BUY
$14.2 - $27.98 $100,621 - $198,266
7,086 Added 46.62%
22,286 $390,000
Q4 2019

Jan 28, 2020
SELL
$14.4 - $19.99 $286,704 - $398,000
-19,910 Reduced 56.71%
15,200 $265,000
Q3 2019

Nov 04, 2019
BUY
$15.32 - $21.92 $393,233 - $562,642
25,668 Added 271.85%
35,110 $538,000
Q2 2019

Jul 29, 2019
BUY
$18.5 - $28.14 $8,639 - $13,141
467 Added 5.2%
9,442 $196,000
Q1 2019

Apr 29, 2019
BUY
$17.99 - $24.65 $161,460 - $221,233
8,975 New
8,975 $208,000

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.77B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email